June 8, 2022 -- Vizgen has announced the expansion of its product roadmap and the availability of the Formalin-Fixed Paraffin-Embedded (FFPE) Human Immuno-oncology data release, as the company seeks to provide the research community with the power of spatial genomics.
The new publicly available FFPE Human Immuno-oncology dataset, which was generated with Vizgen's Merscope platform, represents the largest public data set for single-cell spatial genomics ever released, according to the company.
Vizgen product roadmap updates for the second half of 2022 include: FFPE Sample Preparation Solution enabling Multiplexed Error Robust Fluorescence In Situ Hybridization (MERFISH) measurements on FFPE tissue samples; Protein Co-detection Kit for the simultaneous detection of RNA and proteins during a standard MERFISH experiment, enabling multiomics measurements; and 1,000 plex gene panels for the detection of up to 1,000 gene targets within a single MERFISH experiment, resulting in higher gene target coverage.
The updates were announced at the Advances in Genome Biology and Technology 2022 General Meeting.